HomeNYSE:MRK

NYSE:MRK

Navigating Merck Stock Before Q1 Earnings

Navigating Merck Stock Before Q1 Earnings

April 22, 2024

FDA Issues Another Setback for Merck’s Chronic Cough Drug

FDA Issues Another Setback for Merck’s Chronic Cough Drug

December 21, 2023

Merck Achieves Primary Endpoint in Muscle-Invasive Bladder Cancer Study with Keytruda

Merck Achieves Primary Endpoint in Muscle-Invasive Bladder Cancer Study with Keytruda

October 6, 2023

Merck, Eisai Terminate Keytruda-Lenvima Combination Cancer Trial

Merck, Eisai Terminate Keytruda-Lenvima Combination Cancer Trial

August 28, 2023

Merck Stock: Too Expensive for my Taste

Merck Stock: Too Expensive for my Taste

February 22, 2023